Transarterial Chemoembolization (TACE) is a minimally invasive, targeted treatment for liver tumors, particularly hepatocellular carcinoma and certain metastatic liver lesions. Under the expert care of Dr. Sanghamitra Saha, MBBS, MD, FSVIR, TACE combines precise imaging techniques with advanced interventional radiology to deliver chemotherapy directly to the tumor while minimizing exposure to healthy liver tissue.
TACE works by catheterizing the blood vessels supplying the tumor and delivering a concentrated dose of chemotherapeutic agents directly into the tumor, followed by embolic materials to block its blood supply. This dual approach restricts tumor growth, reduces size, and improves the effectiveness of treatment. The procedure is guided by angiography, ensuring optimal placement of the catheter and precise delivery of therapy.
One of the key advantages of TACE is its minimally invasive nature, which significantly reduces recovery time compared to traditional surgery. Patients typically experience fewer complications, less pain, and shorter hospital stays. TACE can be performed as a standalone treatment or in combination with other therapies such as surgery, systemic chemotherapy, or radiofrequency ablation, depending on the patient’s condition and tumor stage.
At Apeksha Hospital, patient safety and comfort are paramount. Dr. Saha and her team employ advanced imaging technology to monitor the procedure in real-time, ensuring accuracy, minimizing risks, and tailoring treatment to each patient’s specific needs.
By integrating expertise, technology, and personalized care, TACE at Apeksha Hospital offers an effective, minimally invasive solution for liver cancer patients, improving survival rates, controlling tumor progression, and enhancing quality of life.
